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Abstract: Seaweeds, or macroalgae, may be a good dietary iodine source but also a source of excessive
iodine intake. The main aim in this study was to describe the iodine status and thyroid function
in a group of macroalgae consumers. Two urine samples were collected from each participant
(n = 44) to measure urinary iodine concentration (UIC) after habitual consumption of seaweed. Serum
thyroid stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), and peroxidase
autoantibody (TPOAb), were measured in a subgroup (n = 19). A food frequency questionnaire
and an iodine-specific 24 h recall were used to assess iodine intake and macroalgae consumption.
The median (p25–p75) UIC was 1200 (370–2850) µg/L. Median (p25–p75) estimated dietary iodine
intake, excluding macroalgae, was 110 (78–680) µg/day, indicating that seaweed was the major
contributor to the iodine intake. TSH levels were within the reference values, but higher than in
other comparable population groups. One third of the participants used seaweeds daily, and sugar
kelp, winged kelp, dulse and laver were the most common species. Labelling of iodine content was
lacking for a large share of the products consumed. This study found excessive iodine status in
macroalgae consumers after intake of dietary seaweeds. Including macroalgae in the diet may give
excessive iodine exposure, and consumers should be made aware of the risk associated with inclusion
of macroalgae in their diet.
Keywords: iodine; seaweed; urinary iodine status; thyroid function; iodine excess; food and nutrition
security; new marine resources
1. Introduction
Iodine is an essential micronutrient required for the synthesis of thyroid hormones [1]. It is found
in few foods of terrestrial origin [2], however, in countries where fodder is enriched with iodine, milk,
dairy products and eggs may be good dietary sources [3,4]. Marine foods, such as fish and shellfish are
naturally high in iodine due to the high iodine concentration in seawater [2]. Seaweeds, or macroalgae,
may contain high amounts of iodine [5,6]. Macroalgae is commonly used in Asian cultures [7–9],
especially Japan, China and Korea, where edible macroalgae are commonly consumed in soups, sushi,
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as seaweed salads, snacks and in other dishes [7,9–11]. During recent years, macroalgae has entered
the global food market, and has become increasingly popular in the western part of the world [12,13].
In Europe, macroalgae represents a potential new dietary iodine source, and has also been considered
as an especially healthy food or even “super food” [14–17].
Both iodine deficiency and excess may increase the risk of developing a thyroid disorder, hence,
the relationship between iodine intake and the risk of developing a thyroid disorder is U-shaped [18].
Excessive iodine intake may develop into hypothyroidism or hyperthyroidism, both with or without
goiter, depending on the initial and current iodine status and current thyroid function [19,20].
Additionally, acute excessive iodine intake may adversely impact the thyroid [21]. This may be of
particular concern for vulnerable groups, such as pregnant women and individuals with thyroid
autoimmunity [19,20]. Excessive iodine intake from dietary macroalgae has been associated with thyroid
dysfunction (subclinical hypothyroidism) in otherwise healthy adults in Asian populations [22,23].
Although consumption of macroalgae has become increasingly popular in western countries
during recent years, little is known about the iodine status and thyroid function in macroalgae
consumers. The European Food Safety Authorities (EFSA) has requested more knowledge on iodine
content of dietary seaweed as well as data on macroalgae consumption [24]. Further, the Norwegian
Committee for Food and Environment has highlighted consumers of macroalgae as a potential risk
group for excessive iodine intakes in the Norwegian population [25]. The aim of this study is to
describe iodine intake and iodine status in a group of macroalgae consumers in Norway, and to report
on parameters of thyroid function. We also describe the frequency of habitual macroalgae consumption,
where the dietary macroalgae are procured, and the species that are consumed.
2. Materials and Methods
2.1. Recruitment of Study Group
Convenience sampling was used to recruit 44 consumers of macroalgae during September, October
and November 2019. We included frequent macroalgae consumers, defined as habitual consumption
of macroalgae on a weekly basis. Information about the study and an invitation to participate were
broadcast on platforms where consumers of macroalgae were likely to retrieve the information, such as
webpages and social media groups. This was determined by searching the web and by talking to key
informants from different macroalgae social networks of Norway. We also contacted stores in Oslo
and Bergen, the two largest cities in Norway, where macroalgae can be purchased, i.e., health food
stores, international food stores and the fish market in Bergen. When participants were enrolled, they
were encouraged to invite acquaintances to participate in order to facilitate snowball sampling [26].
Participants provided informed written consent. The present study was conducted according to the
guidelines in the Declaration of Helsinki and was approved by the Regional Committee for Medical
and Health Research Ethics Norway (2015/1845).
2.2. Sample
In total, 70 individuals volunteered for the study. Of these, 24 individuals chose not to participate
for unknown reasons, leaving 46 participants enrolled by signing and returning the written informed
consent form. Two individuals not consuming seawater macroalgae were excluded from the analysis,
leaving a study population of 44 participants. Participation flow is found in Figure 1.
The participants (n = 44) answered questions on background information (age, weight, sex, height,
educational level, smoking habits, country of birth, years living in Norway, languages, known thyroid
disease, use of thyroid medication and planning of pregnancy). Two participants reported use of
Levaxin. We do not have data regarding use of other medications than thyroid medication.
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Figure 1. Participation flow. * Two participants were excluded as they used freshwater algae and an 
algae supplement for omega-3 fatty acids. 
The participants (n = 44) answered questions on background information (age, weight, sex, 
height, educational level, smoking habits, country of birth, years living in Norway, languages, known 
thyroid disease, use of thyroid medication and planning of pregnancy). Two participants reported 
use of Levaxin. We do not have data regarding use of other medications than thyroid medication. 
2.3. Urinary Iodine Concentration 
All participants delivered two urine samples. The participants were encouraged to consume 
macroalgae in the same manner as usual, and were instructed to sample their urine 3–4 and 7–8 h 
after consumption. The pre-determined sampling intervals were chosen based on the investigation 
of urinary iodine excretion in humans after consumption of Ascophyllum nodosum, conducted by 
Combet et al. [27]. Urine samples were stored refrigerated (0–4 °C) until delivery at the Institute of 
Marine Research (IMR), where the samples were stored at minus 20 °C pending analysis of urinary 
iodine concentration (UIC), by inductively coupled plasma mass spectrometry (ICP-MS). For the 
determination of iodine, 500 μL urine was diluted in 4.5 mL 1% tetramethylammonium hydroxide 
(TMAH) and filtered using a sterile membrane with a 0.45 μm pore size and a single-use syringe. 
Samples were analyzed against a urine calibration curve (standard addition curve). Internal validity 
of the method was verified with certified reference material (SRM); Seronorm Trace Elements Urine. 
The measurement uncertainty for iodine is 20% for the whole measurement range [28]. 
The two urine samples for each individual were used to calculate the mean UIC for each 
participant, and further the median UIC for the group. Daily iodine intake was estimated from UIC 
using the following equation: daily iodine intake = UIC (μg/L) ÷ 0.92 × (0.0009 L/hour/kg × 24 h/day) 
× body weight (kg) [29]. 
We assessed whether UIC had remained stable, increased or decreased between the first and 
second urine sample. Based on a measurement uncertainty of 20%, a change larger than ±10% from 
the first urine sample to the second urine sample was considered as an increase or decrease. 
2.4. Thyroid Hormones in Blood Samples 
Blood samples for analysis of thyroid function were obtained from a subgroup (n = 19). For 
logistical reasons, blood samples were not taken from participants (n = 25) living far from where the 
clinical laboratory (Fürst Medical Laboratories) was located (Oslo and Bergen). Venous blood 
samples for serum preparation were collected in BD Vacutainer® SST™ vials II Advanced, and set to 
coagulate for a minimum of 30 min. Within 60 min after phlebotomy, the samples were centrifuged 
(1000–3000 G, room temperature, 10 min). Post-separation, serum samples were sent to Oslo and 
stored refrigerated (2–8 °C) overnight, pending analysis at Fürst Medical Laboratories in Oslo, 
Figure 1. Participation flow. * Two participants were excluded as they used freshwater algae and an
algae supplement for omega-3 fatty acids.
2.3. Urinary Iodine Concentration
All participants delivered two urine samples. The participants were encouraged to consume
macroalgae in the same manner as usual, and were instructed to sample their urine 3–4 and 7–8 h
after consumption. The pre-determined sampling intervals were chosen based on the investigation
of urinary iodine excretion in humans after consumption of Ascophyllum nodosum, conducted by
Combet et al. [27]. Urine samples were stored refrigerated (0–4 ◦C) until delivery at the Institute of
Marine Research (IMR), where the sampl s were stored at minus 20 ◦C pending analysis of urinary
iodine conce tration (UIC), by inductively coupled plasma mass spectrom t y (ICP-MS). For the
det rmi ation of iodin , 500 µL urine was diluted i 4.5 mL 1% tetramethylammonium hydroxide
(TMAH) and filt r d using a sterile membrane with a 0.45 µm pore size and a single-use syringe.
Sampl s were analyzed ag inst a urine calibration curve (standard addition curve). Internal validity
of the method was verified with c rtified refer nce material (SRM); Seronorm Trace Elements Urine.
The measurement u certainty for iodine is 20% for the whole easurement range [28].
The two urine samples for each i dividual were used to calculate the an UIC for each participant,
and further the median UIC for the group. Daily iodine intake was e tim ted from UIC using th
following equation: daily iodine intak = UIC (µg/L) ÷ 0.92 × (0.0009 L/h ur/kg × 24 h/day) × bod
weight (kg) [29].
W ass ss d whether UIC had remained stable, increased or decreased between the first and
second urine sample. Based on a measurement uncertainty of 20%, a ch nge larger than ±10% from
the first urine sample to t second urine sample was considered as an increase or decrease.
2.4. Thyroid Hormones in Blood Samples
Blood samples for analysis of thyroid function were obtained from a subgroup (n = 19).
For logistical reasons, blood samples were not taken from participants (n = 25) living far from
where the clinical laboratory (Fürst Medical Laboratories) was located (Oslo and Bergen). Venous
blood samples for serum preparation were collected in BD Vacutainer® SST™ vials II Advanced,
and set to coagulate for a minimum of 30 min. Within 60 min after phlebotomy, the samples were
centrifuged (1000–3000 G, room tempe ature, 10 min). Post-separation, serum sam les were sent
t O lo and st red refrigerated (2–8 ◦C) vernight, pending analysis at Fürst Medical Laboratories
in Oslo, Norway, the following d y. Thy oid stimulating hormone (TSH), free thyroxine (fT4), free
triiodothyronine (fT3) and hyroid peroxidase antibodies ( nti-TPO) were analyzed in serum using
magnetic separatio and detection by chemiluminescence, lab led with acridinium est , on an Advia
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Centaur XPT Immunoassay system (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA).
Reference values established by Fürst Medical Laboratories were used.
2.5. Assessment of Iodine from Food and Dietary Supplements, Excluding Macroalgae
Iodine intake from iodine-rich foods and iodine-containing supplements was calculated for the
last 24 h (I24-h), and habitual iodine intake was calculated from a short food frequency questionnaire
(FFQ). The I24-h included questions about intake of milk and yogurt (number of glasses), cheese, eggs
(including dishes), and fish (lean and fatty fish for dinner and/or as spread), as these are the main food
items contributing to iodine intake in Norway. Milk and dairy products are together with egg and
fish the most important dietary iodine sources in Norway [30] since the cow’s fodder is enriched with
iodine. Use of iodized salt by the food industry is not mandatory in Norway, and as the available
iodized table salt is only allowed to contain up to 5 µg iodine/g salt, the contribution is neglectable.
The reported food intakes were multiplied with the iodine concentration for each specified food to
obtain the estimated iodine intake. The FFQ included 32 different food items, with frequencies ranging
from “rarely/never” to “five times daily or more”. The recall period was the last four weeks. Of the
32 food items, 11 questions assessed iodine-rich foods, including five questions about milk and dairy,
five questions about fish and fish products and one question about eggs. Reported intake of milk,
cheese, fish, and egg were converted to daily amounts and multiplied with the iodine concentration
for each food item. Standard portion sizes for each of the different food items were used [31]. In all
calculations, iodine concentrations reported in the Norwegian Food Composition Table [32] or in
Nerhus et al. [33] were used. We applied values from Nerhus et al. for lean fish, cheese, whey cheese
and eggs. To account for iodine contributed by foods and dishes not covered by the assessed food
items, 30 µg was added to each estimated total intake as suggested by others [34].
Participants were asked to report if they used iodine-containing supplements (non-algae), such as
multivitamins or mineral supplements, and report the quantity of iodine and frequency of consumption.
The daily quantity of iodine contributed by iodine-containing supplements was calculated and added
to both the calculated 24 h intake (I24-h) and the habitual intake from food (FFQ).
The participants were asked about vegetarian practices, where “vegetarians” were defined by
exclusion of meat and fish and inclusion of milk, dairy products and eggs. We defined those excluding
meat, but including fish, milk and eggs as “pesco-vegetarians” and those excluding meat and milk but
included fish and eggs as “pesco-vegetarians excluding milk”. “Vegans” were defined by exclusion
of all animal source products in the diet. The variable vegetarian practice (n = 7) included all
vegetarian/vegan practices combined.
2.6. Assessment of Macroalgae Consumption
Questions regarding intake of macroalgae in the diet were divided into three categories; (1) whole
food macroalgae, (2) macroalgae-containing foods and (3) macroalgae-containing supplements.
Macroalgae in the diet were investigated as habitual consumption (FFQ) using the following frequency
intervals: “daily”, “4–6 times/week”, “1–3 times/week”, “less than once a week” and “other”, and as
consumption in the last 24 h. Further, questions regarding types of products, macroalgae species, where
the product was purchased, and how it was used as a part of the diet were included. All questions
regarding macroalgae in the diet were open ended except for given frequency intervals. In addition,
the participants provided detailed information about macroalgae consumed on the same day as they
took the urine samples.
2.7. Assessment of Iodine from Macroalgae
There are no established portion sizes for edible macroalgae. Therefore, only participants who
provided sufficient information about the quantity of macroalgae intake and the iodine concentration
from the package labelling could be included for the estimation of iodine intake from macroalgae.
This information was only provided by a small number of participants (n = 10 for the 24 h intake,
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n = 11 for the habitual intake). Therefore, the difference between the estimated iodine intake from
UIC and the iodine intake from food and non-algae supplements estimated from the survey was
used to estimate iodine intake from macroalgae for all participants (n = 44), using the following
calculation: estimated iodine intake from macroalgae = estimated iodine intake from UIC - estimated
iodine intake from food (I-24h) µg/day. For example: estimated iodine intake from UIC = 3000 µg/day;
estimated iodine intake from food (I-24h) = 200 µg/day. Estimated iodine intake from macroalgae:
3000 − 200 µg/day = 2800 µg/day. For three (I-24H) and five (FFQ) participants, the values were
negative, as the estimated iodine intakes from food were probably overestimated. In those cases,
the value zero was imputed into the dataset and used when calculating central and variation values of
the variable.
2.8. Statistical Methods
IBM SPSS 26 (Statistical Package for the Social Sciences) was used to perform all statistical analyses.
p-value < 0.05 was used as statistical value of significance in all tests, unless other is noted. Dependent
variables were checked for normality using Q–Q plots and the Shapiro–Wilk test. Due to the skewed
distribution and low number, non-parametric tests were used. Independent group differences were
examined using the Mann–Whitney U test for comparison of two groups, and Kruskal–Wallis test was
used for comparison of categories with more than two groups. Spearman’s rank correlation was used
to evaluate the linear relationship between continuous variables.
3. Results
Characteristics of the study participants are presented in Table 1. The mean age was 46 years,
and 61% were women. Seventy-five percent were born in Norway, while 23% were born in other
European countries and one person outside Europe. The participants born outside Norway had
significantly higher median UIC (2225 µg/L) than those born in Norway (620 µg/L), p = 0.01. The 16%
who reported a vegetarian dietary practice had significantly lower median UIC (165 ug/L) than those
not reporting a vegetarian diet (1285 ug/L), p = 0.045.
UIC measured 3–4 and 7–8 h after ingestion of macroalgae is presented in Table 2, together with
habitual and 24 h iodine intake. Median (p25–p75) UIC for the first and second urine sample was
1080 (300–2150) µg/L and 1050 (340–3450) µg/L, respectively. The median daily iodine intake estimated
from UIC, representing total iodine intake from all sources, was 2430 µg/day. The estimated median
iodine intake from non-algal foods and supplements was 110 µg/day for the last 24 h, while the habitual
iodine intake (FFQ) was 260 µg/day. The estimated iodine intake from macroalgae alone, based on the
estimated iodine intake from UIC, was 2160 µg/day and 2200 µg/day for the habitual (FFQ) and 24 h
intake, respectively.
As shown in Table 2, the median UIC was similar between the first and the second sample.
The mean SD UIC was considerably higher for the second sample; however, the differences were not
statistically significant (p = 0.717). Stability in UIC from the first to the second urine sample is shown
in Table S1. There was an increase in UIC from the first to the second sample for 48% (n = 21) of the
participants, while a decrease for 32% (n = 14) and 21% (n = 9) remained stable. There was a significant
correlation between UIC from the two time-points. A visual presentation of the change in UIC is
presented in Figure S1a–c.
The participants reported the type of macroalgae consumed on the day of the urine sample.
The median UICs were highest among the participants who reported consumption of sugar kelp,
with a median UIC of 2900 µg/L (Table 3).
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Table 1. Descriptive characteristics of seaweed consumers in Norway (n = 44) a.
Characteristics d UIC b µg/L p-Value c
Age, mean 46.1 ± 12.4
Male 16 [36.4] 1400 (428–2119) 1.00
Female 27 [61.4] 825 (250–5200)
BMI, kg/m2 25.4 ± 5.4
Country of birth 0.01
Norway 33 [75] 620 (226–2550)
Other 11 [25] 2225 (1550–5700)
Education level
≤High school 10 [23.3] 935 (403–1725) 0.081
≤4 years university/college 10 [23.3] 402 (183–1676)
>4 years university/college 23 [53.5] 2225 (655–5700)
Smoking habits
No 27 [61.4] 1250 (620–2950) 0.366 e
Daily/Occasionally 4 [9.1] 2200 (496–11213)





Number of children 1.3 ± 1.5
Planned pregnancy, next two years 1 [2.3]




Pesco-vegetarian, excluding milk 2 [4.5]
Use of iodine containing supplement 5 [11.4]
a Values are presented as mean ± SD, median (p25–p75), and n [%]. b Urinary iodine concentration (UIC) is given
as the median value based upon a mean of two urine samples taken 3–4 and 7–8 h after seaweed consumption.
c Differences between groups were tested using Mann–Whitney U or Kruskal–Wallis test. d One missing value for
sex, education and smoking habits. e Tested between smokers/former smokers and non-smokers. f Tested between
vegetarian practice (n = 7) and not vegetarian practice (n = 37).
Table 2. Urinary iodine concentration (UIC), habitual iodine intake from food and supplements a, 24 h
iodine intake from food and supplements a and estimated iodine intake from UIC (n = 44).
UIC, µg/L Median p25 p75 Mean ± SD Min, Max P f
1st urine sample b 1080 300 2150 1840 ± 2360 70, 12,000
0.1712nd urine sample c 1050 340 3450 2500 ± 3450 70, 16,000
Mean 1st and 2nd urine sample 1200 370 2850 2170 ± 2770 80, 14,000
Iodine intake, µg/day
I-24H from food and non-algae supplements 110 70 970 390 ± 440 30, 1140
FFQ from food and non-algae supplements 260 150 380 340 ± 490 30, 3300
Daily iodine intake estimated from UIC d 2430 g 500 4630 3750 ± 4770 120, 25,660
Estimated iodine intake from seaweed only e, µg/day
24 h intake (I-24H) 2160 280 4270 3450 ± 4720 0, 25,520
Habitual intake (FFQ) 2200 280 4060 3420 ± 4750 0, 25,530
a Excluding iodine contribution from macroalgae b Approximately 3–4 h after intake of macroalgae. c Approximately
7–8 h after intake of macroalgae. d Estimated 24 h iodine intake from UIC = mean UIC × 0.0235 × body weight [28].
e Calculated from estimated iodine intake from UIC-estimated iodine intake from food and supplements. f Differences
between 1st and 2nd urine sample tested with the Mann–Whitney U test. g A total of 75% (n = 33) had an estimated
intake above 600 µg/day, 64% (n = 28) had an estimated intake above 1100 µg/day, and 55% (n = 24) had an estimated
intake above 1800 µg/day. FFQ: Food frequency questionnaire.
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Table 3. Reported macroalgae consumption on the day of the urine sampling and UIC (µg/L) among
the participants within the reported species consumed (n = 44).
Macroalgae Type Macroalgae Consumption the Day of Urine Sample UIC, µg/L
n [%] Median (p25–p75)
Sugar kelp 10 [23] 2900 (1170–6587)
Mix a 12 [27] 1350 (629–4613)
Badderlocks, winged
kelp 9 [21] 1650 (565–1800)
Rockweed, egg wrack 4 [9] 335 (123–596)
Oarweed 1 [2] -
Wakame 1 [2] -
Dulse 1 [2] -
Laver 1 [2] -
Unspecified 5 [11] 250 (144–1305)
a The species reported in the category of mix were dulse, wakame, sugar kelp, badderlocks, bladderwrack and
horned wrack.
Descriptive data of thyroid hormone levels for the subsample (n = 19) are presented in Table 4.
Of the 19 participants in the subgroup, one participant had a TSH value above the laboratory reference
(4.0 mIU/L), and two participants were peroxidase autoantibody (TPOAb) positive. The median
(p25–p75) UIC (mean value of the first and the second sample) in the subsample was 360 (145–1150)
µg/L. Of note, these participants had significantly lower median UIC than the participants who did not
deliver a blood sample (median: 1800 µg/L), p < 0.005.
Table 4. Thyroid hormone levels (thyroid stimulating hormone (TSH), free triiodothyronine (fT3),
and free thyroxine (fT4)) and thyroid peroxidase antibodies (anti-TPO) in seaweed consumers in
Norway (n = 19).
Thyroid Hormones and TPOAb Median p25 p75 Mean ± SD Min, Max Reference
Serum TSH (mIU/L) a 1.8 1.4 2.6 2.0 ± 0.9 0.6, 4.2 0.2–4.0
Serum fT4 (pmol/L) 16.0 14.5 17.2 15.9 ± 1.9 12.5, 20.1 11.0–23.0
Serum fT3 (pmol/L) 5.0 4.6 5.4 5.0 ± 0.5 4.3, 5.9 3.5–6.5
TPOAb (kU/L) n [%] Min, Max
<34 13 [68]
<34,784≥34–100 4 [21] <100
>100 2 [11]
Differences between TSH, fT4, and fT3 were tested with the Mann–Whitney U test showing p = 0.051, p = 0.194
and p = 0.853, respectively. a One participant: elevated TSH and fT4 within reference range. TPOAb: peroxidase
autoantibody; TSH: thyroid stimulating hormone; fT4: free thyroxine; fT3: free triiodothyronine (fT3).
Table 5 shows the frequency of habitual seaweed consumption (last four weeks) and procurement
details. Most participants used whole macroalgae products (n = 41). Products with macroalgae as an
ingredient were used by 35 of the participants, and macroalgae as a supplement by five participants.
Most of the participants used products from more than one category. In the category of whole food
products, 23% consumed macroalgae daily. Across the product categories, about 30% reported daily
consumption of macroalgae. For the wholefood macroalgae, 42% were personally harvested by the
participants, and 42% were store-bought products. About 29% of the participants consuming foods
with macroalgae had bought the products in a chain store. A total of 22% of the whole food products
had iodine declaration on the package, whereas 14% and 40% of foods and supplements, respectively,
had iodine declaration. The participants reported that the declared content of iodine ranged from
63 µg/g to 35,000 µg/g for whole food macroalgae and 0.6 µg/g to 3360 µg/g for macroalgae containing
foods. Sugar kelp (Saccharina latissima), winged kelp (Alaria esculenta), and dulse (Palmaria palmata) were
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the species that most participants reported to consume habitually in the category of whole macroalgae
products. An overview of macroalgae species consumed habitually (FFQ) is reported in Table 6.
Table 5. Frequency of habitual macroalgae consumption and procurement frequencies among

















consumption a n [%]
b n [%] b n [%] b n [%] b,c
Median
(p25–p75)
Daily 10 [23] 5 [11] 2 [5] 13 [30] 655 (253–2013)
4–6 times/week 8 [18] 5 [11] 0 10 [23] 2550 (564–6625)
1–3 times/week 16 [36] 7 [16] 1 [2] 15 [34] 1115 (203–2850)
Monthly 4 [9] 16 [36] 2 [5] 6 [14] 1525 (893–3438)
Other 3 [7] 2 [5] 0 0 -
Procurement frequencies n [%] d n [%] d n [%] d
Personally harvested 17 [42] 7 [20] 0 - -
Common food store (chain) 1 [2] 10 [29] 1 [20] - -
Common food store (not chain) 2 [5] 1 [3] 1 [20] - -
Online store 4 [10] 0 1 [20] - -
Health food store 2 [5] 0 0 - -
Restaurant 0 2 [6] 0 - -
Unspecified store 8 [20] 5 [14] 0 - -
Product declaration of iodine e
Yes 9 [22] 5 [14] 2 [40] - -
No 21 [51] 25 [71] 2 [40] - -
a Consumption frequencies: 41 used wholefood seaweed products, 35 used foods containing macroalgae
(one missing), 5 used seaweed containing supplements. Multiple answers were allowed. b Percent of total
number of participants (n = 44). c If different frequencies were given for different products, the most frequent
were used. This might be underestimating the frequency of use, as different products may have been sued at
different days. d Within macroalgae category: whole food macroalgae (n = 41); food containing macroalgae (n = 35);
supplements containing macroalgae (n = 5).e Eleven missing values for wholefood macroalgae, five missing values
for food containing macroalgae, and one missing value for supplement containing macroalgae. Percentage is given
within category, including missing.
Table 6. Habitual consumption (the last 4 weeks) of different macroalgae species reported among
macroalgae consumers in Norway (n = 44).
Category English Latin Habitual Consumption a
n [%] b
Brown algae
Sugar kelp Saccharina latissima 17 [39]
Badderlocks, winged kelp Alaria esculenta 16 [36]
Bladderwrack Fucus vesiculosus 5 [11]
Sea spaghetti Himanthalia elongata 5 [11]
Wakame Undaria pinnatifida 4 [9]
Horned wrack Fucus serratus 4 [9]
Oarweed Laminaria digitata 4 [9]
Japanese kelp Laminaria japonica/Saccharina japonica 2 [5]
Rockweed, egg wrack Ascophyllum nodosum 2 [5]
Green algae Sea lettuce Ulva lactuca 4 [9]
Gut weed, mermaids’ hair Enteromorpha intestinalis 1 [2]
Red algae
Dulse Palmaria palmata 15 [34]
Laver Porphyra purpurea 8 [18]
Wrack siphon weed Polysiphonia (vertebrata) lanosa 1 [2]
a Categorized from open-ended questions of whole food macroalgae products, multiple answers allowed; thus,
several species may have been consumed for the participants under the specific species category. b Percent of total
(n = 44).
Several reasons for including macroalgae in the diet were given by the participants (Table S2.
The most common reasons were taste (n = 27), richness in nutrients (n = 15) and because it was
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considered sustainable (n = 9). Other reasons given were positive health effects/healthy; exciting;
to ensure iodine in the diet; a substitute for fish; healing effect; and to reduce salt intake. Macroalgae
was used in different ways by the participants (Table S3, where seasoning/spice (n = 24), sushi (n = 8)
and snacks (n = 8) were the most common ways.
4. Discussion
The median (p25–p75) UIC among the 44 macroalgae consumers included in this study was
1200 (370–2850) µg/L after macroalgae consumption, and the estimated median (p25–p75) iodine
intake from macroalgae alone was 2200 (280–4060) µg/day. Sugar kelp, winged kelp, dulse and laver
were the most used macroalgae species. The participants who had included sugar kelp in their diet
the day of the urine sampling had a median UIC of 2900 µg/L, which was higher than for the other
reported species. Thirty percent reported habitual daily use of macroalgae, while 23% used macroalgae
4–6 times/week and about 50% included macroalgae in the diet 1–3 times/week or less frequently.
The median UIC considerably exceeds the cut-off value of 300 µg/L from WHO/UNICEF/IGN,
indicating excessive iodine nutrition [35]. Further, the median estimated iodine intake of 2430 µg/day
was four times higher than the tolerable upper intake level (UL) from EFSA of 600 µg/day [36].
Three-quarters of the participants exceeded the UL of 600 µg/day, while 64% exceeded the UL from The
National Academy of Medicine (NAM), formerly called the Institute of Medicine, of 1100 µg/day [29].
Fifty-five percent exceeded the lowest observed adverse effect level (LOAEL) for iodine intake of
1800 µg/day, used both by EFSA and NAM. Therefore, the risk of adverse health effects from excessive
iodine intake in this study population can be considered high. However, a large inter-individual
variation in UIC was seen, as the measured UIC ranged from 70–16,000 µg/L. We believe this indicates
large differences in iodine concentration in different macroalgae species, and/or large differences in
the quantity of macroalgae consumed. This is in line with an Irish study, examining iodine content of
19 commonly consumed macroalgae species, where the iodine content between species was highly
variable [37]. For the species with the highest iodine content, sugar kelp, only 0.04 g was required to
meet the daily recommended daily intake of 150 µg [37].
The median daily iodine intake from food alone was considerably lower than the UIC. This indicates
that macroalgae were the main contributor to dietary iodine in this study. Due to the design of the
study and the lack of accurate data on the iodine content of the consumed macroalgae products, we
cannot report on the bioavailability of iodine. However, as the contribution of iodine from macroalgae
was high, and by far exceeded the contribution from other foods, the absorbed amount of iodine is
likely to be substantial. Bioavailability of iodine from macroalgae in humans is estimated to vary from
50 to 100% [22,38,39]. The difference in bioavailability between species has been suggested to be related
to the share of iodine stored in inorganic and organic form, such as mono- and di-iodothyrosine (MIT
and DIT), in macroalgae, where humans absorb inorganic iodine, such as potassium iodine (KI) or
iodate (IO3-), more effectively than organically bound iodine, e.g., MIT and DIT [38]. However, factors
such as iodine status and current thyroid function may also be of importance for iodine uptake in
humans [36].
In this study, one participant had subclinical hypothyroidism, as indicated by a TSH above
the reference value, and two had positive TPOAb with thyroid function tests within the laboratory
references. Compared with median TSH levels for men and women (1.5 mIU/L) in a large-scale
Norwegian study (Nord-Trøndelag Health Study (HUNT)) [40], the median TSH level of 1.8 mIU/L
observed in the present study was higher. Similarly, the mean serum TSH (2.0 ± 0.9 mIU/L) was
higher than mean TSH (1.5 (±0.02) mIU/L) of a disease-free population in the U.S. National Health and
Nutrition Examination Survey (NHANES III) [41]. In our study, we cannot say whether the TSH levels
increased due to macroalgae ingestion because of the nature of the observational study design.
The participants providing blood samples (n = 19) had significantly lower median UIC (390 µg/L)
than the remaining participants (n = 25, UIC: 1800 µg/L). Of note, the median estimated daily iodine
intake from UIC for the subgroup was 540 µg/day and did not exceed the UL by EFSA of 600 µg/day,
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hence, one would not expect an impact on thyroid function. Thyroid function, however, might have
been differently affected in the remaining group having an excessive iodine intake. Additionally,
the time of the blood samples were not standardized according to macroalgae intake, thus, a transient
rise in TSH may have occurred unnoticed. Further studies are required to examine thyroid function in
macroalgae consumers with an excessive iodine intake. Previously, several case studies have reported
iodine-induced thyroid dysfunction in adults consuming seaweed [42–45]. Thyroid dysfunction has
also been seen in new-born babies after excessive maternal iodine intake from macroalgae [46,47].
A Japanese study reported elevated TSH after ingestion of high iodine from Kombu [22], and the
authors advised against consuming excessive amounts of seaweed. Three population studies found an
increase in UIC and TSH after macroalgae supplementation in euthyroid adults [8,27,48]. In all three
studies, UIC and hormone levels returned to baseline after cessation of macroalgae supplementation.
These studies were of short duration and do not reflect the effect that excessive iodine may have on the
thyroid gland after years of macroalgae consumption. In a population with long-term excessive iodine
exposure, the prevalence of subclinical and overt hypothyroidism was 14% and 4.5% in postpartum
women [49], and 22% and 1.5% in a follow-up three years later [50]. The prevalence of subclinical
hypothyroidism in young children from the same population was 9.3% [51]. In a systematic review and
meta-analysis, the risk of subclinical hypothyroidism was significantly higher among men and women
with iodine excess than among those with adequate iodine intakes [52]. Furthermore, the systematic
review showed a dose-related increase in the prevalence of subclinical hypothyroidism as the level of
UIC increased. Hence, macroalgae with a high concentration of iodine should be used with caution,
especially in vulnerable groups such as pregnant women, as the fetus is susceptible for high maternal
iodine intake and maternal thyroid function [53,54]. Further, as a large cohort study found that even
mildly elevated TSH preconception could result in negative pregnancy outcomes, women in fertile
age should also use high-iodine macroalgae with care [55]. Other known vulnerable groups to iodine
excess are people with thyroid disease or thyroid autoimmunity [56].
Macroalgae were most commonly used as a seasoning-/spice-/flavor enhancer. Sugar kelp
(Saccharina latissima) was the most popular species in our study. Concentrations of iodine in sugar
kelp are reported as high as 7200 µg/g dry weight [57]. After sugar kelp, winged kelp (Alaria esculenta)
and dulse (Palmaria palmata) were the species that most participants mentioned in the dietary survey
in the category of whole macroalgae products. Winged kelp has been shown to be high in iodine
(181–1070 µg/g dry weight), while dulse is lower (72–293 µg/g dry weight) [57].
A large share of the products the participants reported to consume were not labeled with iodine
concentration. Similarly, in the UK, only 22 products out of 224, (10%), stated information regarding
iodine content [12]. Due to variations in iodine concentration with season, harvesting location, age,
and size of the macroalgae, storage and processing conditions, the iodine concentration is difficult to
determine without specific analysis of products. The iodine concentration for the same species may
vary considerably [5]. For the products in our study with declaration of iodine, the concentration
was highly variable, ranging from 63 µg/g to 35,000 µg/g for whole food macroalgae and 0.6 µg/g to
3360 µg/g for macroalgae containing foods. With such variations in iodine content and with products
without iodine declaration, it is difficult to decide if a product is safe to consume.
Strengths and Limitations
This is the first study to examine iodine status and thyroid function among macroalgae consumers
in Norway, thereby providing new insights into an area of limited research. The urine samples in
this study were collected with a predetermined time-interval (3–4 h and 7–8 h) after consumption of
macroalgae. These time intervals were chosen based on the investigation of urinary iodine excretion
in humans after consumption of Ascophyllum nodosum, [27]. However, several different macroalgae
species were used among the participants in this study, and the excretion curve may be different
due to the varying bioavailability of iodine from different species and/or foods. It is considered a
strength that we have two urine samples per participant, however, it must be noted that UIC from this
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study provides information about the iodine status after macroalgae consumption. If macroalgae are
consumed only once a week, the total iodine intake per week may remain low, and the UIC is only
representative for a day with consumption of macroalgae.
During the participant recruitment, there were 24 passive dropouts, meaning that they reported
interest in the study and received a consent form and the necessary supplies to participate, but never
followed up further. We do not know whether these individuals were different from the study
population. Additionally, the sample size was small, and we cannot exclude the possibility of selection
bias. The subsample providing information about thyroid function was small and not representative
of the whole study population, as the median UIC differed significantly from the group that only
provided urine samples. Conclusions about thyroid function for the whole study sample can therefore
not be drawn.
Macroalgae was divided into three product categories: macroalgae as a whole food, products
with macroalgae as an ingredient, and macroalgae as a supplement, such as pills/tablets or powder.
Most participants were recruited from specific areas where harvested macroalgae were used as whole
food. Due to limited time, participants using commercially available macroalgae products were
probably underrepresented, as recruitment in health food stores, global food stores or chain stores
was time-consuming.
Macroalgae may also be a source of contaminants, such as heavy metals and especially inorganic
arsenic [58]. The potential exposure risk of these, and other undesirable components from macroalgae,
was not evaluated in this study and requires further investigation.
5. Conclusions
Wholefood macroalgae was the most consumed macroalgae product, and sugar kelp, winged
kelp, dulse and laver were the most common species. Iodine status in macroalgae consumers is
excessive after intake of macroalgae. The UIC among the participants was highly variable, ranging
from 70–16,000 µg/L, indicating a large variation in iodine concentrations in the macroalgae products
consumed, confirmed by the reported iodine content of the declared products. However, for many
products, iodine declaration was lacking. Macroalgae with low-level iodine used in appropriate
amounts may be a good dietary source of iodine. Still, precaution must be taken before consuming
macroalgae as it may give a high iodine exposure. Population groups vulnerable to high iodine intakes
should avoid consuming macroalgae in order to reduce the risk of negative health consequences of
excessive iodine intakes. Our study sample was small, and larger studies preferably with a controlled
design including repeated measures, would be useful for future research within this topic. Studies
examining the content and bioavailability of iodine and heavy metals in macroalgae and macroalgae
products are also warranted.
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